|
 |
DaptomycinThis page contains recent news articles, when available, and an overview of Daptomycin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Daptomycin (when available) A lipopeptide antibiotic that inhibits gram-positive bacteria For the treatment of complicated skin and skin structure infections caused by susceptible strains of the following Gram-positive microorganisms such as Staphylococcus aureus (including methicillin-resistant strains), Streptococcus pyogenes, Streptococcus Mechanism Of Action: Not Available News Articles on Daptomycin Trial date set for Cubist suit against Teva on Cubicin - Dec 13, 2009 Daptomycin is marketed in the US and internationally under the brand name Cubicin (daptomycin for injection) as therapy for serious skin and bloodstream ... pharmabiz.com Cubist snares promising antibiotic in $402.5M Calixa buyout - Dec 14, 2009 Gram positive therapy Cubicin (daptomycin for injection) for the treatment of complicated skin infections and bacteremia caused by MRSA," Bonney says. ... FierceBiotech Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and ... - Dec 29, 2009 The company's lead product, CUBICIN (daptomycin for injection), an intravenous, or IV, antibiotic, developed and launched in the US accounted for majority ... PRMinds (press release) Cubist Pharmaceuticals and the New England Patriots Radio Network Recognize ... - Dec 28, 2009 In the US, Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. ... Earthtimes (press release) Trial Date Set for Cubicin Patent Litigation - Dec 11, 2009 Daptomycin is marketed in the US and internationally under the brand name CUBICIN® (daptomycin for injection) as therapy for serious skin and bloodstream ... PharmaLive.com (press release) OTC: PolyMedix Successfully Completes Main Portions of Phase 1B Clinical Study ... - Dec 18, 2009 There are many forms of Staph bacteria which are resistant to many antibiotics, including marketed drugs such as vancomycin, linezolid, and daptomycin. ... RTT News (press release) Cubist Pharmaceuticals Completes Acquisition Of Calixa Therapeutics - Dec 16, 2009 In the US, Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. ... FOXBusiness 专家看好我国微生物资æº?å¼€å?‘ - Dec 15, 2009 ...ä¸‰æ˜¯å¯»æ‰¾æ–°çš„æ´»æ€§æ›´å¥½çš„æŠ—ç”Ÿç´ ï¼Œå¦‚è¾¾æ‰˜éœ‰ç´ (Daptomycin)是目å‰?惟一能抑制G＋细è?Œç»†èƒžè†œä¸Šç‰¹æœ‰æˆ?分脂磷å£?é…¸å?ˆæˆ?çš„æŠ—ç”Ÿç´ ï¼Œé€šè¿‡ä¸Žç»†è?Œç»†èƒžè†œç»“å?ˆå¯¼è‡´è†œç”µä½?迅速去æž?化ã€? ... 中国生物技术信息网 About this author: - Nov 5, 2009 Cubist has one marketed product, an intravenous (IV) antibiotic, CUBICIN (daptomycin for injection). CUBICIN is approved in the United States for the ... Seeking Alpha (blog) The Boston Globe names Cubist to Globe 100's Top Places to Work '09 - Nov 9, 2009 In the US, Cubist markets CUBICIN® (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. ... WELT ONLINE www.StockMarketingInc.com: Tuesday's Pick!! GSAE - Green Star Alternative ... - Nov 10, 2009 In the US, Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. ... Trading Markets (press release) Methicillin-Resistant Staphylococcus aureus Strain Linked to High Mortality ... - Nov 3, 2009 However, we do have alternatives now such as daptomycin or linezolid." Funding for this study was provided by Henry Ford Health System. ... DG News Cubist Pharmaceuticals to Present at Lazard Capital Markets 6th Annual ... - Nov 3, 2009 In the US, Cubist markets CUBICIN ® (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. ... WELT ONLINE Cubist Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and ... - Nov 9, 2009 The company's lead product, CUBICIN (daptomycin for injection), an intravenous, or IV, antibiotic, developed and launched in the US accounted for majority ... PR-Inside.com (Pressemitteilung) DotW: Same As The Old Boss - Oct 23, 2009 The firm is best known for the antibiotic Cubicin (daptomycin), which is on track for half a billion dollars in revenue this year as methicillin-resistant ... The IN VIVO Blog (blog) Theravance, Inc. Q3 2009 Earnings Call Transcript - Oct 27, 2009 ...where you are at a premium or a discount because it can vary pretty broadly, particularly for Daptomycin based upon our indication and things like that. ... Seeking Alpha (blog) Cubist Pharmaceuticals, Inc. - SWOT Analysis - Aarkstore Enterprise - Oct 29, 2009 The company markets Cubicin (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides, in the US. ... PRMinds (press release) Daptomycin use in infants: report of two cases with peak and trough... - Aug 27, 2007 Correspondence: Dr DK Benjamin Jr, Department of Pediatrics, Duke Clinical Research Institute, PO Box 17969, Durham, NC, USA. E-mail: danny.benjamin@duke. ... Nature.com Daptomycin vs. Vancomycin for Complicated Skin/Skin Structure … - Feb 20, 2008 Susan L. Davis, Pharm.D.; Peggy S. McKinnon, Pharm.D.; Levi M. Hall, Pharm.D.; George Delgado, Jr., Pharm.D.; Warren Rose, Pharm.D.; Robert F. Wilson, MD; ... Medscape Daptomycin Is Clinically More Rapidly Effective Than Comparator for … - Apr 5, 2007 By Chris Berrie. MUNICH, GERMANY -- April 5, 2007 -- The cyclic lipopeptide antibiotic daptomycin elicits statistically significant earlier responses than ... DG News Novartis superbug drug gets wider EU approval - Sep 5, 2007 The antibiotic, also known by its chemical name daptomycin, first received European approval in January 2006, the company said in a statement. ... Reuters Cubicin® (Daptomycin): Treatment of S. Aureus Bacteremia/Endocarditis - Aug 1, 2006 By Erica Tam, Yanina Goykhman, Jessica C. Song, and Paul Hsiao, Erica Tam and Yanina Goykhman are PharmD Candidates, University of the Pacific, Paul Hsiao, ... Pay-Per-View - Infectious Disease Alert - Factiva, from Dow Jones … infections respond to Daptomycin.(Infectious Diseases) | Article... - Feb 1, 2005 Drug-resistant bloodstream infections respond to Daptomycin. ... BOSTON -- Daptomycin may be an effective option for difficult-to-treat gram-positive ... Pay-Per-View - Family Practice News - HighBeam Research FDA OKs staph infection drug tested at Duke - Aug 17, 2006 Daptomycin, which is marketed by Cubist as Cubicin, was originally approved by FDA officials on Sept. 12, 2003, for use in treating skin infections. ... Bizjournals.com Pioneering new drug to fight MRSA is given go-ahead in Scotland - Mar 11, 2008 The Scottish Medicines Consortium recommended Cubicin (daptomycin) to treat severe infections caused by the superbug. The decision was welcomed by ... Scotsman Daptomycin (Systemic).(Drug overview) - Aug 1, 2006 Daptomycin (DAP-toe-mye-sin) belongs to the family of medicines called antibiotics. Antibiotics are medicines used in the treatment of infections caused by ... Free with registration - USP DI-Volume II, Advice for the... - AccessMyLibrary.com Stregnths and weaknesses of daptomycin use for MRSA infections - Sep 24, 2007 ...* New class of antibiotic with activity against MRSA that has been used in the US to treat sepsis and severe infections. * As or more expensive than other ... Gerson Lehrman Group Daptomycin vs. resistant blood infections.(Infectious Diseases) |... - Jan 15, 2005 Daptomycin vs. resistant blood infections.(Infectious Diseases) ... find Internal Medicine News articles. BOSTON -- Daptomycin may be an effective option ... Pay-Per-View - Internal Medicine News - HighBeam Research … With Neutropenia Respond to Daptomycin Treatment: Presented at … - Sep 21, 2008 By Crina Frincu-Mallos, PhD. PHILADELPHIA -- September 21, 2008 -- Daptomycin is effective and well tolerated in neutropenic cancer patients, according to ... DG News Daptomycin Knocks Out Most Infections in Dialysis Patients: Presented... - Nov 20, 2006 By Ed Susman. SAN DIEGO, CA -- November 20, 2006 -- The antibiotic agent daptomycin achieved a response in 85% of dialysis patients who were diagnosed with ... DG News New Licence for Cubicin(R) (daptomycin), the First in a Novel Class... - Sep 12, 2007 The launch of daptomycin for the treatment of both methicillin-sensitive and resistant Staphylococcus aureus (MSSA and MRSA) bloodstream infections ... Free with registration - PR Newswire - AccessMyLibrary.com Daptomycin studied for bone, joint infections: the drug's off-label... - Feb 1, 2005 BOSTON -- Daptomycin may effectively treat gram-positive bone and joint infections and may be less likely than standard antimicrobials to cause drug ... Pay-Per-View - Family Practice News - Factiva, from Dow Jones Daptomycin bests many gram-positive infections.(Clinical Rounds) - Dec 1, 2006 SAN FRANCISCO -- Results from a large registry of patients treated with daptomycin for a variety of gram-positive infections revealed that the overall ... Pay-Per-View - Skin & Allergy News - Factiva, from Dow Jones Press Release: New Licence for Cubicin(R) (daptomycin), the First in... - Sep 12, 2007 New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart ... Pay-Per-View - PR Newswire - HighBeam Research Anti-Infectives; Daptomycin, linezolid, and quinupristin/dalfopristin... - Dec 6, 2005 2005 DEC 6 - (NewsRx.com) -- Daptomycin, linezolid, and quinupristin/dalfopristin were used to manage infections in cancer patients. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Daptomycin deemed approvable for S. aureus bacteremia Tx.(News) | … - May 1, 2006 Daptomycin deemed approvable for S. aureus bacteremia Tx.(News) ... find Skin & Allergy News articles. ROCKVILLE, MD. -- The Food and Drug Administration's ... Pay-Per-View - Skin & Allergy News - HighBeam Research Antibiotics; Synthesis and derivatization of daptomycin chronicled - Mar 1, 2005 2005 MAR 1 - (NewsRx.com & NewsRx.net) -- Investigators from Germany have described the synthesis and derivatization of daptomycin. ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Daptomycin approved in Europe for MRSA bacteremia and right sided en ... - Sep 7, 2007 The large study comparing daptomycin to a comparator group of either vancomycin plus gent or a semi-synthetic penicillin plus gent showed no statistically ... Gerson Lehrman Group FDA panel: approve daptomycin for S. aureus Tx.(Food and Drug … - May 1, 2006 FDA panel: approve daptomycin for S. aureus Tx.(Food and Drug Administration)(Staphylococcus aureus ) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research Article: Daptomycin looks like a possible option for treating... - Jan 15, 2005 Daptomycin looks like a possible option for treating difficult bone and joint infections.(Infectious Diseases) ... find Internal Medicine News articles. Pay-Per-View - Internal Medicine News - HighBeam Research CUBICIN(R) Outcomes Registry and Experience (CORE(R)) Marks … - Oct 21, 2008 Daptomycin appears effective against a variety of clinical presentations of IE. ... Daptomycin appears to be effective in treating catheter-related ... RedOrbit University of Marburg; Synthesis and derivatization of daptomycin … - Mar 2, 2005 ..."Daptomycin is a branched cyclic nonribosomally assembled acidic lipopeptide, which is the first clinically approved antibiotic of this class. ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones International Approvals: Cubicin and Temodal - Feb 6, 2006 6, 2006 — The European Commission has approved daptomycin intravenous infusion ... Patients receiving daptomycin should be monitored for the development of ... Medscape Press Release: New Licence for Cubicin(R) (daptomycin), the First in... - Sep 12, 2007 New Licence for Cubicin(R) (daptomycin), the First in a Novel Class of Antibiotic, is Announced Today for the Treatment of Serious Bloodstream and Heart ... Pay-Per-View - PR Newswire Europe - HighBeam Research Antibiotics; Synthesis and derivatization of daptomycin chronicled - Mar 5, 2005 2005 MAR 5 - (NewsRx.com & NewsRx.net) -- Investigators from Germany have described the synthesis and derivatization of daptomycin. ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones FDA panel: approve daptomycin for S. aureus Tx.(Food and Drug … - May 1, 2006 ROCKVILLE, MD. -- The Food and Drug Administration's Anti-Infective Advisory Committee unanimously supported the approval of daptomycin (Cubicin) for ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones Daptomycin vs. resistant blood infections.(Infectious Diseases) - Jan 15, 2005 BOSTON -- Daptomycin may be an effective option for difficult-to-treat gram-positive bloodstream infections, John Segreti, MD, reported at the annual ... Pay-Per-View - Internal Medicine News - Factiva, from Dow Jones Article: Daptomycin deemed approvable for S. aureus.(Infectious … - Apr 15, 2006 Daptomycin deemed approvable for S. aureus.(Infectious Diseases)(Staphylococcus aureus) ... find Family Practice News articles. Rockville, Md. -- The Food ... Pay-Per-View - Family Practice News - HighBeam Research Efficacy and safety of daptomycin versus vancomycin or teicoplanin... - Apr 1, 2007 This study will evaluate the efficacy and safety of daptomycin compared to ... Condition Intervention Phase Skin Diseases, Infectious Drug: daptomycin Phase ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Infection; Effects of arbekacin, daptomycin, and tigecycline on … - Jan 17, 2005 2005 JAN 17 - (NewsRx.com & NewsRx.net) -- Recently published research from the United States reported on the testing of clinical glycopeptide-intermediate ... Pay-Per-View - Health & Medicine Week - Factiva, from Dow Jones Staph faces a stronger opponent - Aug 17, 2006 The additional firepower, a prescription antibiotic called daptomycin, comes at a time when ... But daptomycin, a liquid antibiotic given intravenously, ... News & Observer Scientists Strike Blow In Superbugs Struggle - Dec 11, 2007 Scientists in Manchester have been doing work on calcium dependent antibiotics (CDA), which belong to the same family of acidic lipopeptides as daptomycin. ... sciencedaily.com Infection; Effects of arbekacin, daptomycin, and tigecycline on … - Jan 21, 2005 2005 JAN 21 - (NewsRx.com & NewsRx.net) -- Recently published research from the United States reported on the testing of clinical glycopeptide-intermediate ... Pay-Per-View - Drug Week - Factiva, from Dow Jones Antimicrobial Resistance; Daptomycin is active against all Gram... - Sep 26, 2006 ..."The antimicrobial susceptibility patterns of 9322 contemporary (2002-2004) Gram-positive bacterial isolates collected from 31 medical centers in 14 ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Scientists strike blow in superbugs struggle - Dec 5, 2007 Scientists in Manchester have been doing work on calcium dependant antibiotics (CDA), which belong to the same family of acidic lipopeptides as daptomycin. ... PhysOrg.com Cubist Pharmaceuticals Files sNDA to Expand CUBICIN(R) Label for … - Sep 26, 2005 In the US, Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of antiinfectives called lipopeptides. ... RedOrbit Cubist's Daptomycin Cleared For Cardiac, Blood Infections - May 30, 2006 By Randall Osborne. Despite a somewhat ambivalent vote by its advisory panel, the FDA approved a label expansion for Cubist Pharmaceuticals Inc.'s ... BioWorld Online - BioWorld Online Efficacy and safety of daptomycin versus vancomycin or teicoplanin... - Jul 1, 2007 Sponsored by Novartis. This study will evaluate the efficacy and safety of daptomycin compared to vancomycin or teicoplanin for the treatment of complicated ... $4.95 - Journal of Drugs in Dermatology - ECNext Infection; Effects of arbekacin, daptomycin, and tigecycline on … - Jan 22, 2005 2005 JAN 22 - (NewsRx.com & NewsRx.net) -- Recently published research from the United States reported on the testing of clinical glycopeptide-intermediate ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Safety and efficacy of daptomycin for the treatment of complicated... - Jul 1, 2007 Sponsored by Novartis. This study will evaluate the safety and efficacy of daptomycin against complicated skin and skin-structure infections in adults. $4.95 - Journal of Drugs in Dermatology - ECNext Hub International Ltd acquires Flynn Insurance Agency - Deal Snapshot... - Mar 10, 2008 Cubicin (daptomycin) Disease Hub Infections Description Cubicin contains daptomycin…scientific committee of the European Agency for the Evaluation of ... Pay-Per-View - deals - Alacra Store Anti-Infectives; Daptomycin is effective antibiotic against Gram... - Feb 8, 2005 According to recent research published in the journal Expert Opinion on Pharmacotherapy, "Daptomycin is a novel member of a new class of antimicrobial ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Article: Daptomycin bests many gram-positive infections.(Clinical... - Dec 1, 2006 Daptomycin bests many gram-positive infections.(Clinical Rounds) ... find Skin & Allergy News articles. SAN FRANCISCO -- Results from a large registry of ... Pay-Per-View - Skin & Allergy News - HighBeam Research Cubist Pharmaceuticals Licenses Rights for Development and … - Mar 22, 2007 In the US, Cubist markets CUBICIN[R] (daptomycin for injection), the first antibiotic in a new class of antiinfectives called lipopeptides. ... Free with registration - Business Wire - AccessMyLibrary.com Wayne State University; Daptomycin is effective antibiotic against... - Feb 9, 2005 According to recent research published in the journal Expert Opinion on Pharmacotherapy, "Daptomycin is a novel member of a new class of antimicrobial ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones Cubist Pharmaceuticals Stock Trading Halted Today; FDA Advisory … - Mar 6, 2006 In the US, Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of antiinfectives called lipopeptides. ... Free with registration - Business Wire - AccessMyLibrary.com Anti-Infectives; Daptomycin is effective antibiotic against Gram... - Feb 12, 2005 According to recent research published in the journal Expert Opinion on Pharmacotherapy, "Daptomycin is a novel member of a new class of antimicrobial ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Cubist Pharmaceuticals Reports Third Quarter 2007 Results: Total … - Oct 17, 2007 Total net product revenues for CUBICIN([R]) (daptomycin for injection) increased 52% from the prior year, from $50.3 million in the third quarter of 2006 to ... Free with registration - Business Wire - AccessMyLibrary.com Daptomycin for skin infections. - May 31, 2006 Chiron Corp in Uxbridge launched the new antibiotic Cubicin (daptomycin) in Great Britain. Cubicin is indicated for the treatment of complicated skin and ... Pay-Per-View - Die Pharmazeutische Industrie - Factiva, from Dow Jones Article: Daptomycin studied for bone, joint infections: the drug's... - Feb 1, 2005 Daptomycin studied for bone, joint infections: the drug's off-label use may be less likely to cause drug resistance due to long-term therapy. Pay-Per-View - Family Practice News - HighBeam Research Cubist Pharmaceuticals Completes Offering of $350 Million in 2.25% … - Jun 6, 2006 In the US, Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of antiinfectives called lipopeptides. ... Genetic Engineering News - Genetic Engineering News (press release) Novartis makes cash offer of L305 million for UK biotech firm... - Jun 12, 2006 With Chiron, it gained the rights to Cubicin (daptomycin) for Europe and additional markets for the treatment of complicated skin and soft-tissue infections ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Cubist Pharmaceuticals Announces Fourth Quarter 2006 US Net Product … - Jan 8, 2007 In the US, Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of antiinfectives called lipopeptides. ... Genetic Engineering News - Genetic Engineering News (press release) Novartis launches Cubicin for MRSA - Sep 14, 2007 Cubicin (daptomycin) works by killing bacteria cells to eliminate infection, ... "Daptomycin is a fast-acting agent in these potentially difficult ... Pharmafocus AstraZeneca Licenses Rights for the Development and … - Dec 4, 2006 Inc. (NASDAQ: CBST) for the development and commercialisation of the antibiotic CUBICIN® (daptomycin for injection) in China and certain other countries ... webwire.com daptomycin Cubist receives approval, USA (S aureus bacteremia and … - Jun 5, 2006 ...caused by meticillin-resistant and -susceptible Staphylococcus aureus (MRSA/MSSA). This follows an approvable letter from the regulatory body on 24 March ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones daptomycin Cubist approvable, USA (S aureus bacteremia and … - Apr 3, 2006 ...endocarditis. The letter stipulates that the product is approvable for this indication subject to the FDA and Cubist reaching agreement on the label. ... Pay-Per-View - R & D Focus Drug News - Factiva, from Dow Jones Cubist Pharmaceuticals Statement on the Death of Dr. Francis P. Tally. - Oct 3, 2006 He was, however, deeply involved in the landmark trial he initiated which led to the recent FDA approved label expansion for CUBICIN([R]) (daptomycin for ... Free with registration - Business Wire - AccessMyLibrary.com Cubicin Approved for Marketing in Canada - Sep 26, 2007 Oryx Pharmaceuticals licensed Cubicin (daptomycin for injection) for the Canadian market from Cubist. The company expects to launch Cubicin in Canada by ... FDA news - FDA news (subscription) Cubist Pharmaceuticals Announces Fourth Quarter 2004 Cubicin … - Jan 10, 2005 ...in net revenue (unaudited) for its flagship antibiotic product Cubicin(R) (daptomycin for injection) during the fourth full quarter since launch. ... Free with registration - Business Wire - AccessMyLibrary.com New Treatment, First in Years, Demonstrated For Dangerous Staph … - Aug 26, 2006 Daptomycin had been approved by the FDA in 2003 for treating skin infections ... Cubist Pharmaceuticals, which manufactures daptomycin, funded the study. ... Virtual Medical Centre - The Virtual Medical Centre Dangerous Staph Infections: New Treatment Demonstrated - Aug 22, 2006 Daptomycin had been approved by the FDA in 2003 for treating skin ... One group received six milligrams of daptomycin per kilogram of body weight, ... Medical News Today - Medical News Today (press release) Business Update; New plant to provide additional production of Cubicin - Mar 26, 2005 According to the company, Cubicin (daptomycin for injection) is currently the only once-daily bactericidal antibiotic approved in the US indicated for the ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Merger and Acquisition Scenario - Nov 29, 2008 Intravenous Cubicin (Daptomycin). Phase I/Phase II Clinical Stage Products ... Intravenous Cubicin (Daptomycin); HepeX-B (Dual Human Monoclonal Antibodies) $250.00 - Revere Reports - Revere Drug Development; Cubist Pharmaceuticals to purchase 2% reduction in ... - Mar 29, 2005 ...(LLY) a 2% reduction in the royalties payable to Lilly on net sales of Cubicin (daptomycin for injection). Cubist acquired worldwide development and ... Pay-Per-View - Science Letter - Factiva, from Dow Jones Endocarditis; Treatment phase complete in the Cubicin endocarditis/ … - Apr 3, 2005 Cubicin (daptomycin for injection), according to the company, is currently the only once-daily bactericidal antibiotic approved in the US indicated for the ... Pay-Per-View - Heart Disease Weekly - Factiva, from Dow Jones Determination of regulatory review period for purposes of patent … - Jun 14, 2006 The US Food and Drug Administration (FDA) has determined the regulatory review period for Cubicin (daptomycin, US Patent No. ... Pay-Per-View - Federal Register - Factiva, from Dow Jones Merger and Acquisition Scenario - Nov 22, 2008 Intravenous Cubicin (Daptomycin). Phase I/Phase II Clinical Stage Products ... Intravenous Cubicin (Daptomycin); HepeX-B (Dual Human Monoclonal Antibodies) ... $250.00 - Revere Reports - Revere New antibiotic knocks out - Sep 15, 2006 The FDA has approved the antibiotic daptomycin to treat systemic infections ... Daptomycin was put on the US market for the treatment of S aureus skin and ... National Review of Medicine Merger and Acquisition Scenario - Jun 14, 2008 Intravenous Cubicin (Daptomycin). Narrow Spectrum. Dermatology ... Intravenous Cubicin (Daptomycin). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Antibiotics; New research from Japan and the United States in the... - Oct 28, 2006 According to their report, "Daptomycin is a lipopeptide antibiotic with activity ... Because the mechanism of action of daptomycin is calcium-dependent ... Pay-Per-View - Obesity, Fitness & Wellness Week - Factiva, from Dow Jones Health24 - News, Bacterial & Viral infections - Aug 17, 2006 Daptomycin has previously been approved for treating skin infections caused ... In the second trial, daptomycin was about as effective as standard therapy ... Health24.com International Approvals: Cubicin, BeneFIX, Aricept - Sep 17, 2007 September 17, 2007 — The European Commission has approved daptomycin ... Daptomycin therapy also met primary endpoints for noninferiority compared with ... Medscape Staphylococcal Infections — From the Surface to the Depths - Nov 10, 2006 Forty-two days after the end of therapy, 44% of daptomycin recipients and 42% of ... The authors concluded that daptomycin is not inferior to standard ... Medscape A comparison of available and investigational antibiotics for... - Jan 1, 2007 Daptomycin effectively treats cSSSI but not pneumonia caused by MRSA, ... Daptomycin is a lipopeptide antibiotic. Daptomycin possesses rapid in vitro ... Free with registration - Journal of Drugs in Dermatology - AccessMyLibrary.com Persistent vancomycin and high-level gentamicin-resistant Enterococcus... - Feb 11, 2008 Although the VRE isolate was susceptible to the new lipopeptide antibiotic, daptomycin (minimum inhibitory concentration=2 mg l -1 , using Clinical and ... Nature.com Article: Cubicin.(NEW & APPROVED) - Internal Medicine News | … - Jul 15, 2006 Cubicin.(NEW & APPROVED) ... find Internal Medicine News articles. Cubicin (daptomycin for injection, Cubist Pharmaceuticals) A cyclic lipopeptide antibi... Pay-Per-View - Internal Medicine News - HighBeam Research Drug therapy for heart-endangering staphylococcus infections - Aug 30, 2006 In 2003, this drug, daptomycin, received Food and Drug Administration (FDA) for the ... Daptomycin proved as effective as standard therapy, showing a 44.4% ... European Hospital Daptomycin bei Bakteriämie/Endokarditis: Altes Antibiotikum als neues... - Aug 21, 2006 Durham - Ein altes Antibiotikum, dessen Entwicklung vor mehr als einem Jahrzehnt wegen möglicher Komplikationen zurückgestellt wurde, erweist sich jetzt in ... Deutsches Ärzteblatt Antibiotics; Biosynthesis of lipopeptide antibiotics in Streptomyces ... - May 3, 2006 According to research from the United States, "Daptomycin is a cyclic ... Cubicin (daptomycin-for-injection) was approved in 2003 by the FDA to treat skin ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Antimicrobial Resistance; Antimicrobial agents have excellent... - Oct 17, 2006 ..."Ceftobiprole, daptomycin, and tigecycline showed high activity against all ... Denis continued, "The MIC distribution of daptomycin and tigecycline was not ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Oritavancin Demonstrates Potent and Rapid In Vitro Activity Against … - Sep 19, 2007 Oritavancin was tested in combination with daptomycin, gentamicin, linezolid, moxifloxacin or rifampicin against methicillin-sensitive S. aureus (MSSA), ... $4.95 - PR Newswire - ECNext Press Release: FDA Issues Approvable Letter for Ceftobiprole for … - Mar 18, 2008 Article: Safety and efficacy of daptomycin for the treatment of ... ... Article: Efficacy and safety of daptomycin versus vancomycin or ... ... Pay-Per-View - PR Newswire - HighBeam Research International Approvals: Atripla, Cubicin, Galvus - Oct 22, 2007 On September 24, Health Canada approved daptomycin intravenous infusion ( Cubicin, ... During the regulatory review process, daptomycin was available upon ... Medscape Resistance to 3 Antibiotics Found in Commensal Enterococci - Mar 23, 2006 Daptomycin and linezolid are approved for use in humans only, while QD is approved for ... Susceptibility testing showed 99% were susceptible to daptomycin, ... Medscape Netherlands Corporate News - CUBICIN krijgt groen licht van de ' … - Nov 18, 2005 About CUBICIN(R) (Daptomycin Powder for Solution for Infusion) CUBICIN is the first of ... In the US, Cubist markets CUBICIN(R) (daptomycin for injection), ... Netherlands Corporate News - Netherlands Corporate News (persbericht) Researchers show efficacy of first Staph drug for decades - Aug 23, 2006 The FDA has approved the drug, Daptomycin, in 2003 for treating S. ... One group received six milligrams of daptomycin per kilogram of body weight, ... DrugResearcher.com Update on Antibiotic Resistance in Hospitals - Jun 16, 2006 Daptomycin also has potential utility for skin and soft-tissue infections ... Linezolid, daptomycin, and tigecycline are all active in vitro against the ... Medscape SMI steht leicht im Minus - Sep 5, 2007 Der Pharmakonzern Novartis hat von der Europäischen Kommission für das Medikament Cubicin (Daptomycin) die Zulassung für zwei neue Indikationen erhalten. ... BörseGo.de Merger and Acquisition Scenario - Sep 8, 2007 Intravenous Cubicin (Daptomycin). Narrow Spectrum. Dermatology ... Intravenous Cubicin (Daptomycin). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Aug 25, 2007 Intravenous Cubicin (Daptomycin). Narrow Spectrum. Dermatology ... Intravenous Cubicin (Daptomycin). Phase I/Phase II Clinical Stage Products ... $250.00 - Revere Reports - Revere Merger and Acquisition Scenario - Jul 1, 2006 It has one marketed product, CUBICIN (daptomycin for injection), which was launched in the United States in November 2003. ... $250.00 - Revere Reports - Revere USI Holdings Corp acquires Winthrop Insurance Plans - Deal Snapshot -... - Aug 24, 2005 ...$2360.00 …to-treat patient populations when usi ng Cidecin (daptomycin for injection…on the label. C ubist plans to respond to the Approvable… ... Pay-Per-View - deals - Alacra Store Intermediate vancomycin susceptibility in a community-associated MRSA... - Mar 1, 2007 Susceptibilities to daptomycin, linezolid, and tigecycline were performed on the ... Notably, the daptomycin MIC of the April isolate was reproducibly 2 ... Free with registration - Emerging Infectious Diseases - AccessMyLibrary.com Management of Staphylococcus aureus infections. - Dec 15, 2005 Daptomycin only is available for intravenous administration, ... The safety and efficacy of daptomycin for the treatment of complicated skin and ... $4.95 - American Family Physician - ECNext Merger and Acquisition Scenario - Aug 2, 2008 Cubist has one marketed product, an intravenous (IV) antibiotic, CUBICIN (daptomycin for injection). CUBICIN is approved in the United States for the ... $250.00 - Revere Reports - Revere Astellas and Theravance Report Additional Telavancin Data at 47th … - Sep 18, 2007 Comparative Use of Telavancin and Daptomycin Against MRSA in the Neutropenic Murine Thigh Model In this study, mice thigh tissue was injected with MRSA and ... $4.95 - PR Newswire - ECNext Brand Names/Synonyms: Daptomycin is also known by the following brand names and/or synonymsDAPTOMYCIN; Cubicin (TN) Drug Category: Daptomycin is categorized under the following by the FDA: Anti-bacterial Agents; ATC:D06AX Dosage Forms: Not Available Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |